Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inGenetics

Impact of Early Life Adversity on Epigenome at Molecular Level Mapped in Macaques

June 18, 2026
Continue Reading
impact-of-early-life-adversity-on-epigenome-at-molecular-level-mapped-in-macaques
Posted inGenetics

Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine

June 18, 2026
Continue Reading
historic-biotech-ipo,-merck,-protillion’s-ai-deal,-testing-a-lassa–rabies-vaccine
Posted inGenetics

IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings

June 18, 2026
Continue Reading
idbs-and-alchemi-agree-to-accelerate-ai-driven-biopharma-regulatory-filings
Posted inBiotechnology

Moderna’s flu candidate sails through FDA advisory committee in unanimous votes

June 18, 2026
Continue Reading
moderna’s-flu-candidate-sails-through-fda-advisory-committee-in-unanimous-votes
Posted inGenetics

China Sets Framework for Advanced Therapeutic Development

June 18, 2026
Continue Reading
china-sets-framework-for-advanced-therapeutic-development
Posted inGenetics

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelain

June 18, 2026
Continue Reading
perseverance,-persistence-key-to-car-t-success,-say-ross-prize-winners-carl-june-and-michel-sadelain
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

spatial-transcriptomic-clocks-reveal-local-cellular-interactions-influence-brain-aging
Posted inGenetics

Spatial Transcriptomic Clocks Reveal Local Cellular Interactions Influence Brain Aging

December 18, 2024
Certain cells in the brain create a nurturing environment, enhancing the health and resilience of their neighbors, while others promote…
Read More
novartis,-bioage-take-on-age-related-diseases-in-$550m-pact
Posted inBiotechnology

Novartis, BioAge take on age-related diseases in $550M pact

December 18, 2024
Freshly public BioAge Labs has secured a multi-year partnership with Novartis that focuses on age-related diseases and includes the possibility…
Read More
roche-to-bring-mass-spec-to-routine-labs-with-new-cobas-system’s-european-approval
Posted inMedical Technology

Roche to bring mass spec to routine labs with new cobas system’s European approval

December 18, 2024
Roche has begun rolling out a new diagnostics system that aims to bring the gold-standard accuracy of mass spectrometry to…
Read More
fibrosis-focused-tvardi-to-go-public-via-merger-with-cash-strapped-cara
Posted inBiotechnology

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara

December 18, 2024
Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new…
Read More
merck-&-co.-boosts-glp-1-portfolio-by-paying-$112m-upfront-for-hansoh’s-preclinical-drug
Posted inBiotechnology

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh’s preclinical drug

December 18, 2024
Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for…
Read More
aurion’s-regenerative-eye-disease-med-improves-vision-in-phase-1/2-trial
Posted inBiotechnology

Aurion’s regenerative eye disease med improves vision in phase 1/2 trial

December 18, 2024
The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has improved…
Read More
cognition’s-phase-2-shimmer-results-finally-allow-dementia-drug-to-shine
Posted inBiotechnology

Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine

December 18, 2024
The failure of Cognition Therapeutics’ Alzheimer’s disease candidate CT1812 in the SHINE trial earlier this year may have rubbed off…
Read More
nvidia’s-venture-arm-raises-stake-in-ai-drug-discoverer-genesis-therapeutics
Posted inGenetics

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

December 18, 2024
Evan Feinberg, PhD, founder and CEO of Genesis Therapeutics In the beginning, Genesis Therapeutics spun out from the Stanford University…
Read More
how-the-inflammatory-process-is-influenced-by-the-circadian-rhythm
Posted inGenetics

How the Inflammatory Process Is Influenced by the Circadian Rhythm

December 18, 2024
There are various studies that have explored the role of the body’s circadian rhythm in regulating immune activity. Disruptions in…
Read More
novo-nordisk-taps-photys-for-$186m-cardiometabolic-collab
Posted inBiotechnology

Novo Nordisk taps Photys for $186M cardiometabolic collab

December 17, 2024
With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a concerted…
Read More

Posts pagination

Previous page 1 … 1,978 1,979 1,980 1,981 1,982 … 1,989 Next page
You May Have Missed
novocure-device-fails-to-improve-brain-cancer-patients’-survival-in-phase-3-test
Posted inMedical Technology

Novocure device fails to improve brain cancer patients’ survival in phase 3 test

fda-clears-dexcom’s-stelo-otc-glucose-monitor-for-use-with-children
Posted inMedical Technology

FDA clears Dexcom’s Stelo OTC glucose monitor for use with children

irhythm-hit-by-cyberattack-that-compromised-patient-data,-says-operations-unaffected
Posted inMedical Technology

iRhythm hit by cyberattack that compromised patient data, says operations unaffected

amid-us-investment-tour,-j&j-makes-$1b-stop-in-florida-to-upgrade-contact-lens-plant
Posted inMedical Technology

Amid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plant

Privacy Policy    Terms

Scroll to Top